Cathay Biotech
68806545.511.13% ( -0.52 )
Cathay Biotech (688065)
Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationa...
- Open
- 46.03
- High
- 46.25
- Low
- 45.42
- Prev. Close
- 46.03
- Volume
- 47.07K
- Turnover
- 215.25M
- Avg Price
- 45.73
- Bid/Ask Ratio
- --
- Amplitude
- 1.80%
- 52wk High
- 64.05
- Volume Ratio
- 0.76
- Turnover Ratio
- 0.81%
Cathay Biotech Analyst Rating
View MoreForecast & Rating
May 19, 2026Price forecast
¥68.4450.38%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 30, 2025 at 06:27 AM
Cathay Biotech: The net profit for the third quarter was 142 million yuan, a year-on-year increase of 45.30%
- Zhitong · Oct 9, 2025 at 02:35 AM
Cathay Biotech: Accumulated over 10 million spent on share repurchase for incentives
- Zhitong · Sep 29, 2025 at 09:07 AM
Cathay Biotech plans to launch an employee stock ownership plan in 2025
- Zhitong · Sep 29, 2025 at 08:51 AM
Cathay Biotech authorizes its subsidiary for mutual guarantee, with a limit not exceeding 2 billion
- Zhitong · Sep 29, 2025 at 08:38 AM
Cathay Biotech: The annual production of 500,000 tons of bio-based hexanediamine and 900,000 tons of bio-based polyamide project has been postponed to December 31, 2027
- Zhitong · Aug 15, 2025 at 08:36 AM
Cathay Biotech: Net profit in the first half of the year was 309 million yuan, a year-on-year increase of 24.74%
